Persistence, compliance, discontinuation rates and switch rates in denosumab and bisphosphonate treatment of bone metastases in cancer patients: reasons of switch, osteonecrosis of the jaw (ONJ) and other critical points
- Rivista
- SUPPORTIVE CARE IN CANCER
- Autori
- Rossi M, Gambino A, Cabras M, Alessio M, Fusco V
- Citazione bibliografica
- 2021 Aug;29(8):4185-4186
- DOI
- 10.1007/s00520-021-06100-4